122 related articles for article (PubMed ID: 22184920)
1. [Detection of antibodies to Campylobacter jejuni in pediatrics patients with Gullain-Barré syndrome using different antigen preparations].
Rokosz N; Rastawicki W; Jagielski M; Hetkowska-Abramczyk Z
Med Dosw Mikrobiol; 2011; 63(3):255-61. PubMed ID: 22184920
[TBL] [Abstract][Full Text] [Related]
2. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.
Schessl J; Koga M; Funakoshi K; Kirschner J; Muellges W; Weishaupt A; Gold R; Korinthenberg R
Arch Dis Child; 2007 Jan; 92(1):48-52. PubMed ID: 16920757
[TBL] [Abstract][Full Text] [Related]
3. Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship.
Funakoshi K; Koga M; Takahashi M; Hirata K; Yuki N
J Neurol Sci; 2006 Jul; 246(1-2):163-8. PubMed ID: 16600306
[TBL] [Abstract][Full Text] [Related]
4. Utility of serum Campylobacter specific antibodies in determining prior Campylobacter infection in neurological disease.
Taylor BV; Williamson J; Jones D; Coleman D; Luck J; McGregor A
J Clin Neurosci; 2007 Feb; 14(2):116-21. PubMed ID: 17107803
[TBL] [Abstract][Full Text] [Related]
5. Association study between an outbreak of Guillain-Barre syndrome in Jilin, China, and preceding Campylobacter jejuni infection.
Zhang M; Li Q; He L; Meng F; Gu Y; Zheng M; Gong Y; Wang P; Ruan F; Zhou L; Wu J; Chen L; Fitzgerald C; Zhang J
Foodborne Pathog Dis; 2010 Aug; 7(8):913-9. PubMed ID: 20455754
[TBL] [Abstract][Full Text] [Related]
6. Improved serological diagnosis stresses the major role of Campylobacter jejuni in triggering Guillain-Barré syndrome.
Schmidt-Ott R; Schmidt H; Feldmann S; Brass F; Krone B; Gross U
Clin Vaccine Immunol; 2006 Jul; 13(7):779-83. PubMed ID: 16829615
[TBL] [Abstract][Full Text] [Related]
7. Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain-Barré patients.
Geleijns K; Jacobs BC; Van Rijs W; Tio-Gillen AP; Laman JD; van Doorn PA
J Neuroimmunol; 2004 May; 150(1-2):132-8. PubMed ID: 15081257
[TBL] [Abstract][Full Text] [Related]
8. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders.
Enders U; Karch H; Toyka KV; Michels M; Zielasek J; Pette M; Heesemann J; Hartung HP
Ann Neurol; 1993 Aug; 34(2):136-44. PubMed ID: 8338338
[TBL] [Abstract][Full Text] [Related]
9. [Enzyme-linked immunosorbent assay in the diagnosis of campylobacteriosis].
Jakubczak A; Rastawicki W; Jagielski M
Med Dosw Mikrobiol; 2007; 59(4):359-70. PubMed ID: 18416128
[TBL] [Abstract][Full Text] [Related]
10. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
[TBL] [Abstract][Full Text] [Related]
11. Association of Campylobacter jejuni infection and GuillainBarré syndrome: a cohort study in the northwest of Iran.
Barzegar M; Alizadeh A; Toopchizadeh V; Dastgiri S; Majidi J
Turk J Pediatr; 2008; 50(5):443-8. PubMed ID: 19102048
[TBL] [Abstract][Full Text] [Related]
12. GM1 antibody in Guillain-Barre syndrome after Campylobacter jejuni infection.
Tang J; Yuan J; Hao H
Chin Med J (Engl); 1995 Apr; 108(4):262-4. PubMed ID: 7789212
[TBL] [Abstract][Full Text] [Related]
13. Antibody responses to Campylobacter infections determined by an enzyme-linked immunosorbent assay: 2-year follow-up study of 210 patients.
Strid MA; Engberg J; Larsen LB; Begtrup K; Mølbak K; Krogfelt KA
Clin Diagn Lab Immunol; 2001 Mar; 8(2):314-9. PubMed ID: 11238214
[TBL] [Abstract][Full Text] [Related]
14. [A case-control study on Guillain-Barre syndrome in children of North China].
Wu Z; Wu H; Wang Q; Zhaori G; Wang C; Liang Z; Shan G; Cui S; Pan L; Zheng J; Zuo Q; Zhang Y; Zhang K
Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Sep; 33(5):279-81. PubMed ID: 11864491
[TBL] [Abstract][Full Text] [Related]
15. Detection of preceding Campylobacter jejuni infection by polymerase chain reaction in patients with Guillain-Barré syndrome.
Sinha S; Prasad KN; Pradhan S; Jain D; Jha S
Trans R Soc Trop Med Hyg; 2004 Jun; 98(6):342-6. PubMed ID: 15099989
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of usefulness of commercial recomwell Campylobacter enzyme--linked immunosorbent assays for routine serodiagnosis of Campylobacter jejuni and Campylobacter coli infections].
Rokosz N; Rastawicki W; Jagielski M
Med Dosw Mikrobiol; 2008; 60(4):289-95. PubMed ID: 19382600
[TBL] [Abstract][Full Text] [Related]
17. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.
Jacobs BC; van Doorn PA; Schmitz PI; Tio-Gillen AP; Herbrink P; Visser LH; Hooijkass H; van der Meché FG
Ann Neurol; 1996 Aug; 40(2):181-7. PubMed ID: 8773599
[TBL] [Abstract][Full Text] [Related]
18. [Anti-GQ1b IgG-negative case of overlapping Fisher's and Gullain-Barré syndromes after Campylobacter jejuni (PEN 19) enteritis].
Hayashi Y; Koga M; Takahashi M; Uchida A; Yuki N
Rinsho Shinkeigaku; 2001 Nov; 41(11):801-4. PubMed ID: 12080613
[TBL] [Abstract][Full Text] [Related]
19. Guillain-Barre syndrome and Campylobacter jejuni infection. A study on the etiological characteristics of Guillain-Barre syndrome in China.
Yuan JM; Tang J; Chen QT; Xiao L; Hao HJ; Jia ZD; Huang QH; Liu XZ
Chin Med J (Engl); 1993 Nov; 106(11):845-7. PubMed ID: 8143497
[TBL] [Abstract][Full Text] [Related]
20. Subclass IgG to motor gangliosides related to infection and clinical course in Guillain-Barré syndrome.
Jacobs BC; Koga M; van Rijs W; Geleijns K; van Doorn PA; Willison HJ; Yuki N
J Neuroimmunol; 2008 Feb; 194(1-2):181-90. PubMed ID: 18178257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]